Rapamycin Inhibits Trypanosome Cell Growth by Preventing TOR Complex 2 Formation

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2008 Sep 18

PMID 18796613

Citations 62

Authors

Antonio Barquilla

Jose L Crespo

Miguel Navarro

Affiliations

Soon will be listed here.

Abstract

Target of rapamycin (TOR) kinases control cell growth through two functionally distinct multiprotein complexes. TOR complex 1 (TORC1) controls temporal cell growth and is sensitive to rapamycin, whereas TOR complex 2 (TORC2) is rapamycin resistant and regulates spatial cell growth. Here, we identified two TOR orthologues, TbTOR1 and TbTOR2, in the protozoan parasite Trypanosoma brucei, as well as orthologues of the well-known TORC1 and TORC2 partners, KOG1/raptor and AVO3/rictor. TbTOR proteins differ in their functions, subcellular localization, and rapamycin sensitivity. TbTOR1 controls cell growth by regulating cell cycle, nucleolus structure, and protein synthesis, whereas TbTOR2 coordinates cell polarization and cytokinesis. Rapamycin treatment of bloodstream trypanosomes resulted in a pronounced reduction of cell proliferation, with an EC(50) of 152 nM. Unique for a eukaryote, we observed that rapamycin acted exclusively by preventing TORC2 formation, with no effect on TORC1. Our findings on TOR signaling in this protozoan, which is located in a distal position in the eukaryotic cell lineage, highlight the clinical possibilities of rapamycin derivates and provide valuable insights into understanding rapamycin-mediated inhibition of TORC2.

Citing Articles

Evolutionary conservation and metabolic significance of autophagy in algae.

Laude J, Scarsini M, Nef C, Bowler C Philos Trans R Soc Lond B Biol Sci. 2024; 379(1914):20230368.

PMID: 39343016 PMC: 11449223. DOI: 10.1098/rstb.2023.0368.

TORC1 is an essential regulator of nutrient-controlled proliferation and differentiation in Leishmania.

Myburgh E, Geoghegan V, Alves-Ferreira E, Nievas Y, Grewal J, Brown E EMBO Rep. 2024; 25(3):1075-1105.

PMID: 38396206 PMC: 10933368. DOI: 10.1038/s44319-024-00084-y.

mTORC1 Mediates Biphasic Mechano-Response to Orchestrate Adhesion-Dependent Cell Growth and Anoikis Resistance.

Zhang C, Wang Y, Zhen Z, Li J, Su J, Wu C Adv Sci (Weinh). 2023; 11(6):e2307206.

PMID: 38041494 PMC: 10853740. DOI: 10.1002/advs.202307206.

Autophagy in protists and their hosts: When, how and why?.

Romano P, Akematsu T, Besteiro S, Bindschedler A, Carruthers V, Chahine Z Autophagy Rep. 2023; 2(1).

PMID: 37064813 PMC: 10104450. DOI: 10.1080/27694127.2022.2149211.

Different Drugs, Same End: Ultrastructural Hallmarks of Autophagy in Pathogenic Protozoa.

Pedra-Rezende Y, Macedo I, Midlej V, Mariante R, Menna-Barreto R Front Microbiol. 2022; 13:856686.

PMID: 35422792 PMC: 9002357. DOI: 10.3389/fmicb.2022.856686.

References

Bachmann R, Kim J, Wu A, Park I, Chen J . A nuclear transport signal in mammalian target of rapamycin is critical for its cytoplasmic signaling to S6 kinase 1. J Biol Chem. 2006; 281(11):7357-63. DOI: 10.1074/jbc.M512218200. View

Desai B, Myers B, Schreiber S . FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. Proc Natl Acad Sci U S A. 2002; 99(7):4319-24. PMC: 123646. DOI: 10.1073/pnas.261702698. View

Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S . Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell. 2002; 110(2):177-89. DOI: 10.1016/s0092-8674(02)00833-4. View

Barbet N, Schneider U, Helliwell S, Stansfield I, Tuite M, Hall M . TOR controls translation initiation and early G1 progression in yeast. Mol Biol Cell. 1996; 7(1):25-42. PMC: 278610. DOI: 10.1091/mbc.7.1.25. View

Baldauf S . The deep roots of eukaryotes. Science. 2003; 300(5626):1703-6. DOI: 10.1126/science.1085544. View

Sarbassov D, Ali S, Sengupta S, Sheen J, Hsu P, Bagley A . Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell. 2006; 22(2):159-68. DOI: 10.1016/j.molcel.2006.03.029. View

Zhang X, Shu L, Hosoi H, Murti K, Houghton P . Predominant nuclear localization of mammalian target of rapamycin in normal and malignant cells in culture. J Biol Chem. 2002; 277(31):28127-34. DOI: 10.1074/jbc.M202625200. View

Zhang H, Stallock J, Ng J, Reinhard C, Neufeld T . Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev. 2000; 14(21):2712-24. PMC: 317034. DOI: 10.1101/gad.835000. View

Sarbassov D, Ali S, Kim D, Guertin D, Latek R, Erdjument-Bromage H . Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol. 2004; 14(14):1296-302. DOI: 10.1016/j.cub.2004.06.054. View

10.

Wullschleger S, Loewith R, Hall M . TOR signaling in growth and metabolism. Cell. 2006; 124(3):471-84. DOI: 10.1016/j.cell.2006.01.016. View

11.

Kunz J, Henriquez R, Schneider U, Movva N, Hall M . Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell. 1993; 73(3):585-96. DOI: 10.1016/0092-8674(93)90144-f. View

12.

Matsuo T, Otsubo Y, Urano J, Tamanoi F, Yamamoto M . Loss of the TOR kinase Tor2 mimics nitrogen starvation and activates the sexual development pathway in fission yeast. Mol Cell Biol. 2007; 27(8):3154-64. PMC: 1899950. DOI: 10.1128/MCB.01039-06. View

13.

Tsang C, Bertram P, Ai W, Drenan R, Zheng X . Chromatin-mediated regulation of nucleolar structure and RNA Pol I localization by TOR. EMBO J. 2003; 22(22):6045-56. PMC: 275436. DOI: 10.1093/emboj/cdg578. View

14.

Garcia-Salcedo J, Perez-Morga D, Gijon P, Dilbeck V, Pays E, Nolan D . A differential role for actin during the life cycle of Trypanosoma brucei. EMBO J. 2004; 23(4):780-9. PMC: 381002. DOI: 10.1038/sj.emboj.7600094. View

15.

Wang Z, Morris J, DREW M, Englund P . Inhibition of Trypanosoma brucei gene expression by RNA interference using an integratable vector with opposing T7 promoters. J Biol Chem. 2000; 275(51):40174-9. DOI: 10.1074/jbc.M008405200. View

16.

Zheng X, Florentino D, Chen J, Crabtree G, Schreiber S . TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin. Cell. 1995; 82(1):121-30. DOI: 10.1016/0092-8674(95)90058-6. View

17.

Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg M, Hall A . Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol. 2004; 6(11):1122-8. DOI: 10.1038/ncb1183. View

18.

Martin D, Powers T, Hall M . Regulation of ribosome biogenesis: where is TOR?. Cell Metab. 2006; 4(4):259-60. DOI: 10.1016/j.cmet.2006.09.002. View

19.

Sarbassov D, Ali S, Sabatini D . Growing roles for the mTOR pathway. Curr Opin Cell Biol. 2005; 17(6):596-603. DOI: 10.1016/j.ceb.2005.09.009. View

20.

Schmidt A, Kunz J, Hall M . TOR2 is required for organization of the actin cytoskeleton in yeast. Proc Natl Acad Sci U S A. 1996; 93(24):13780-5. PMC: 19424. DOI: 10.1073/pnas.93.24.13780. View